Patents by Inventor Paul Mulder

Paul Mulder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF NGAL PROTEIN
    Publication number: 20220054493
    Abstract: This invention relates to compounds that are inhibitors of NGAL activity, and applications thereof.
    Type: Application
    Filed: March 6, 2020
    Publication date: February 24, 2022
    Inventors: Frédéric JAISSER, Ernesto MARTINEZ-MARTINEZ, Paul MULDER, Antoine OUVRARD-PASCAUD, Philippe BERNARD, Quoc Tuan DO
  • Post-translation modified cardiac troponin T as a biomarker of a risk for heart failure
    Patent number: 8986936
    Abstract: The present invention relates to methods and kits for the prediction of risk for heart failure using post-translation modified forms of cardiac troponin T as a biomarker.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: March 24, 2015
    Assignees: Inserm (Institut National de la Santa et de la Recherche Medicale), Institute Pasteur de Lille, Le Centre Hospitalier Regional Universitaire de Lille, Universite de Rouen
    Inventors: Florence Pinet, Paul Mulder, Christophe Bauters, Vincent Richard
  • Post-Translation Modified Cardiac Troponin T As A Biomarker Of A Risk For Heart Failure
    Publication number: 20120088259
    Abstract: The present invention relates to methods and kits for the prediction of risk for heart failure using post-translation modified forms of cardiac troponin T as a biomarker.
    Type: Application
    Filed: May 20, 2010
    Publication date: April 12, 2012
    Applicants: INSERM (institut National de la Sante et de la Recherche Medicale), INSTITUT PASTEUR DE LILLE
    Inventors: Florence Pinet, Paul Mulder, Christophe Bauters, Vincent Richard